The Manager Financial Operations, SCM provides support at the study planning stage, as well as throughout the lifecycle of a clinical trial through management of Budget Hub escalations, development of improved processes and providing guidance to Biogen’s CROs. The Manager Financial Operations, SCM will coordinate the in-house financial operations including the development and maintenance of all processes and guidelines along with CRO relationship management with a specific focus on site budgets.

What You’ll Do  

• Provides consistent financial strategy, oversight, and support at both the study and program level for all operating models (Strategic CRO Partner(s), other CROs and/or in house operating model)
• Up-front and ongoing strategic planning specific to the program and needs of individual studies
• Development and approval of global investigative site budgets (GrantPlan)
• Devising, developing, and continually enhancing a robust budget development strategy
• Managing issues and risks by acting as the Budget Hub Lead within GCO for challenges and evaluating investigative site budget escalations;
• Providing negotiation support
• Overseeing development and reporting of Budget Hub metrics; responses to budget escalations, analyzing trends and formulating innovative solutions; providing negotiation support; development and reporting of Budget Hub metrics
• Monitoring KPIs, including cycle times and SIV targets, to ensure adherence to established study timelines
• Developing metrics reporting and review to support process improvement efforts
• Management of employee direct reports and the functional management of FSP contractors.

Who You Are  

You are knowledgeable about budgets and willing to mitigate issues in a collaborative environment. 

• Bachelor’s degree;  MBA/MPA/MPH/JD (or equivalent) preferred but not required
• 8+ years’ experience in the biotechnology/pharmaceutical industry within the site contracting outsourcing space and fully proficient in project management and budget negotiation and execution across Phase I-IV clinical trials
• Strong experience in Clinical Operations and have a thorough understanding of GCP, relevant ICH standards, and FDA/EMA guidelines
• Demonstrated success in working cross-functionally in a global matrix organization

Our mission to find therapies for neurological and rare diseases is a unique focus within our industry and this shared purpose is what connects us as a team. We work together to overcome obstacles and to follow the science. We are resilient as we strive to make an impact on our patients’ lives and on changing the course of medicine. Together, we pioneer. Together, we thrive. 

All your information will be kept confidential according to EEO guidelines.